TIME-STRATIFIED PROGNOSTIC VALUE OF ENDOTHELIAL BIOMARKERS IN ACUTE PANCREATITIS, WITH SOLUBLE E-SELECTIN AS AN EARLY MORTALITY PREDICTOR AND VON WILLEBRAND FACTOR AS A PREDICTOR OF ORGAN FAILURE
Clinical medicine

TIME-STRATIFIED PROGNOSTIC VALUE OF ENDOTHELIAL BIOMARKERS IN ACUTE PANCREATITIS, WITH SOLUBLE E-SELECTIN AS AN EARLY MORTALITY PREDICTOR AND VON WILLEBRAND FACTOR AS A PREDICTOR OF ORGAN FAILURE

Published 2026-05-13

Authors:

R.M. Agayev
Scientific Centre of Surgery named after M.A. Topchubashov
https://orcid.org/0000-0003-0954-1439
A.A. Mammadov
Scientific Centre of Surgery named after M.A. Topchubashov
https://orcid.org/0000-0001-6352-1290
E.A. Iskandarov
The Administration of Regional Medical Divisions
https://orcid.org/0000-0002-4015-3605
F.S. Idrisov
Scientific Centre of Surgery named after M.A. Topchubashov
https://orcid.org/0000-0002-8848-9212

Abstract:
Endothelial dysfunction contributes to severity in acute pancreatitis. Endothelial biomarkers were measured serially on days 1, 3, and 7 in 100 patients with acute pancreatitis. Biomarker patterns differed by clinical outcome and sampling time. In patients with worsened outcome, sE-selectin levels were highest on day 3 (87.35±1.97 ng/mL vs. 58.35±2.49 ng/mL in improved outcome), while von Willebrand factor levels showed divergence on day 7 (141.01±10.96 U/dL vs. 90.85±5.73 U/dL). ROC analysis suggested that day 3 sE-selectin ≥56.9 ng/mL might identify patients at risk for mortality (AUC 0.905; sensitivity 92.3 %, specificity 83.9 %), while day 7 von Willebrand factor ≥105 U/dL showed potential for identifying multiorgan dysfunction risk (AUC 0.746 (95 % CI: 0.596–0.896). sE-selectin elevations corresponded with early clinical worsening, while persistent von Willebrand factor elevation was associated with late organ dysfunction. These preliminary findings support further investigation of time-stratified biomarker assessment in larger, independent cohorts.
Keywords:
acute pancreatitis endothelial dysfunction biomarkers sE-Selectin von Willebrand factor
References:
  1. Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. Acute Pancreatitis Classification Working Group. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013 Jan;62(1):102-11. doi: 10.1136/gutjnl-2012-302779.
  2. Chen Y, Ke L, Meng L, Yang Q, Tong Z, Pan Y, et al. Endothelial markers are associated with pancreatic necrosis and overall prognosis in acute pancreatitis: A preliminary cohort study. Pancreatology. 2017 Jan-Feb;17(1):45-50. doi: 10.1016/j.pan.2016.12.005.
  3. Foote CA, Soares RN, Ramirez-Perez FI, Ghiarone T, Aroor A, Manrique-Acevedo C, et al. Endothelial Glycocalyx. Compr Physiol. 2022 Aug 23;12(4):3781-3811. doi: 10.1002/cphy.c210029.
  4. Garg PK, Singh VP. Organ Failure Due to Systemic Injury in Acute Pancreatitis. Gastroenterology. 2019 May; 156(7): 2008-2023. doi: 10.1053/j.gastro.2018.12.041.
  5. Li H, Hao Y, Yang LL, Wang XY, Li XY, Bhandari S, et al . MCTR1 alleviates lipopolysaccharide-induced acute lung injury by protecting lung endothelial glycocalyx. J Cell Physiol. 2020 Oct;235(10):7283-7294. doi: 10.1002/jcp.29628.
  6. Li H, Wen H, Liu J, Luo X, Pei B, Ge P, et al. The glycocalyx: a key target for treatment of severe acute pancreatitis-associated multiple organ dysfunction syndrome. Hum Cell. 2025;38(4):107. doi: 10.1007/s13577-025-01227-6.
  7. Li L, Tan Q, Wu X, Mou X, Lin Z, Liu T, et al. Coagulopathy and acute pancreatitis: pathophysiology and clinical treatment. Front Immunol. 2024 Oct 31;15:1477160. doi: 10.3389/fimmu.2024.1477160.
  8. Mederos MA, Reber HA, Girgis MD. Acute Pancreatitis: A Review. JAMA. 2021 Jan 26;325(4):382-390. doi: 10.1001/jama.2020.20317.
  9. Nakajima K, Ino Y, Yamazaki-Itoh R, Naito C, Shimasaki M, Takahashi M, et al. IAP inhibitor, Embelin increases VCAM-1 levels on the endothelium, producing lymphocytic infiltration and antitumor immunity. Oncoimmunology. 2020 Oct 27;9(1):1838812. doi: 10.1080/2162402X.2020.1838812.
  10. Rakonczay Z Jr, Deli MA. Blood-brain barrier dysfunction in L-ornithine induced acute pancreatitis in rats and the direct effect of L-ornithine on cultured brain endothelial cells. Fluids Barriers CNS. 2022 Feb 17;19(1):16. doi: 10.1186/s12987-022-00308-0.
  11. Reuken PA, Brozat JF, Quickert S, Ibidapo-Obe O, Reißing J, Franz A, et al. Soluble mannose receptor CD206 and von Willebrand factor are early biomarkers to identify patients at risk for severe or necrotizing acute pancreatitis. J Intensive Care. 2022 Jun 11;10(1):28. doi: 10.1186/s40560-022-00619-2.
  12. Sairam PS, Chowdhury SD, Thomas A, John A, Jaleel R, Kurien RT, et al. Imbalance in the vWF - ADAMTS13 axis exists early in acute pancreatitis and predicts persistent organ failure and pancreatic necrosis-a prospective study. Pancreatology. 2024 Nov;24(7):986-992. doi: 10.1016/j.pan.2024.06.011.
  13. Talukdar R. Acute pancreatitis: translating early mechanisms to bedside management. Indian J Gastroenterol. 2025; 44(3): 748-760. doi: 10.1007/s12664-025-01826-z.
  14. Vanani S, Patel M, Adhvaryu D, Dhvani Ph, Nandwani N, Desai A, et al. S23 Early CRP trends and phenotypes predict mortality in acute pancreatitis: a trajectory-based analysis with implications for resource optimization. Am J Gastroenterol. 2025;120(10S2):S5. doi: 0.14309/01.ajg.0001126552.93065.34.
  15. Walter FR, Harazin A, Tóth AE, Veszelka S, Santa-Maria AR, Barna L, et al. Blood-brain barrier dysfunction in L-ornithine induced acute pancreatitis in rats and the direct effect of L-ornithine on cultured brain endothelial cells. Fluids Barriers CNS. 2022 Feb 17;19(1):16. doi:10.1186/s12987-022-00308-0.
Publication:
«World of Medicine and Biology» Vol. 22 No. 96 (2026) , с. 7-11
УДК 616.37-002-036.11-07:616.12-018.74